OR52H1

Across TCGA pan-cancer cohorts, OR52H1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated OR52H1 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher OR52H1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR52H1 expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

ESCA and SKCM are the cancer types where OR52H1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	II,III,IV	0.160	0.707	<.001	30	view →
SKCM	OS	Median	II,III,IV	0.983	0.830	.013	4	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

OR52H1–ESCA (OS)

Open the ESCA breakdown →